NCT06306482

Brief Summary

The aim of this study is to determine posture and posture related factors in patients with restrictive and obstructive lung disease.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 27, 2024

Completed
9 days until next milestone

Study Start

First participant enrolled

March 7, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 12, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 7, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 7, 2026

Completed
Last Updated

March 12, 2024

Status Verified

March 1, 2024

Enrollment Period

1 year

First QC Date

February 27, 2024

Last Update Submit

March 5, 2024

Conditions

Outcome Measures

Primary Outcomes (9)

  • Evaluation of horizontal alignment of the head anterior view

    Angle between left and right tragus and horizontal will be measured via photographic analysis

    1 day

  • Evaluation of horizontal alignment of the trunk anterior view

    Angle between left and right acromion and horizontal will be measured via photographic analysis Angle between left and right anterior superior iliac spine and horizontal will be measured via photographic analysis. Angle between left and right acromion and left and right anterior superior iliac spine will be measured via photographic analysis.

    1 day

  • Evaluation of horizontal alignment of the head lateral view

    Angle between left-right tragus and C7 spinous process and horizontal will be measured via photographic analysis.

    1 day

  • Evaluation of vertical alignment of the head lateral view

    Angle of acromion and tragus (left-right) and vertical will be measured via photographic analysis.

    1 day

  • Evaluation of horizontal alignment of the trunk lateral view

    Angle between anterior superior iliac spine and posterior superior iliac spina and horizontal will be measured via photographic analysis.

    1 day

  • Evaluation of vertical alignment of the trunk lateral view

    Angle between acromion and greater trochanter and vertical will be measured via photographic analysis.

    1 day

  • Evaluation of horizontal asymmetry trunk in posterior view

    Horizontal asymmetry of scapula in relation to T3 spinous process will be measured via photographic analysis.

    1 day

  • Evaluation of scapulae

    Investigation of posture by photographic analysis upward rotation/ anterior tilt/internal rotation of scapula, scapular elevation, and scapular abduction evaluations will be measured photographic analysis.

    1 day

  • Posture

    Posture will be examined via the Corbin Postural Assessment Scale. The total points of the Corbin Postural Assessment Scale range from 0 to 28 points. A higher point represents worse posture.

    1 day

Secondary Outcomes (13)

  • Functional exercise capacity

    1 day

  • Respiratory Muscle Strength

    1 day

  • Lung function

    1 day

  • Dyspnea

    1 day

  • Peripheral muscle strength

    1 day

  • +8 more secondary outcomes

Study Arms (3)

Group A

Patients with chronic obstructive lung disease, asthma, cystic fibrosis and bronchiectasis.

Group B

Patients with diffuse parenchymal lung diseases

control group

healthy aged matched individuals.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Obstructive and restrictive lung disease and healthy controls will be included in this study according to the inclusion and exclusion criteria.

You may qualify if:

  • Over 55 years old,
  • Stage 1-2-3-4 according to the GOLD,
  • Being clinically stable for the last 4 weeks.

You may not qualify if:

  • Receiving long-term oxygen therapy,
  • Having central and peripheral vestibular disease,
  • Communication problems, known mental and cognitive problems,
  • Having undergone any surgical intervention related to the spine within the last six months,
  • Being diagnosed with CF as a result of two sweat tests,
  • Being over 18 years old.
  • Being in acute pulmonary exacerbation period,
  • Receiving long-term oxygen therapy,
  • Having undergone any surgical intervention related to the spine within the last six months,
  • Diagnosed with asthma according to the Global Strategy for the Prevention and Treatment of Asthma (GINA),
  • Clinically stable for the last 1 month
  • Being over 18 years old.
  • Change in medication for the last 1 month.
  • Having undergone any surgical intervention related to the spine in the last six months,
  • Being over 18 years old,
  • +10 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Aynur Demirel

Ankara, 06100, Turkey (Türkiye)

Location

Hacettepe University

Ankara, 06100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Lung Diseases, ObstructiveLung Diseases

Condition Hierarchy (Ancestors)

Respiratory Tract Diseases

Study Officials

  • Aynur Demirel

    Hacettepe University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator; PT, PhD, Assoc. Prof.

Study Record Dates

First Submitted

February 27, 2024

First Posted

March 12, 2024

Study Start

March 7, 2024

Primary Completion

March 7, 2025

Study Completion

March 7, 2026

Last Updated

March 12, 2024

Record last verified: 2024-03

Locations